This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Rheumatology
Suicidal thought related to pain in one in ten patients with rheumatic or musculoskeletal disease
Read more
Significant gaps in essential RA care across Europe and between European countries revealed
Read more
EULAR launches Time2Work campaign
Read more
No link between cancer and TNF inhibitor use in psoriatic arthritis
Read more
Study debunks theoretical risks of live-attenuated vaccines in paediatric rheumatic disease
Read more
Expert view: How personalised is autoimmunity in 2019?
Read more
New EULAR recommendations for the management of antiphospholipid syndrome in adults
Read more
Patients with Sjögren’s Syndrome gather to take their destiny into their own hands
Read more
Key link discovered between tissue cell type and different forms of arthritis
Read more
Getting closer to finding out why the immune system attacks itself
Read more
Expert view: Refining the use of belimumab in patients with SLE
Read more
Expert view: Beyond TNF-alpha – differentiating PsA and RA
Read more
Deleting gene could help alleviate rheumatoid arthritis, study finds
Read more
Identical twins light the way for new genetic cause of inflammatory arthritis
Read more
Expert view: Immunosenescence vs autoimmunity
Read more
NOVESA Phase IIa trial in patients with systemic sclerosis initiated
Read more
Expert analysis: Challenges in diagnosing connective tissue diseases
Read more
Page 6 of 9
« First
«
...
4
5
6
7
8
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: